Provided by Tiger Fintech (Singapore) Pte. Ltd.

Fennec Pharmaceuticals Inc.

8.25
-0.1800-2.14%
Post-market: 8.250.00000.00%16:20 EDT
Volume:76.32K
Turnover:631.67K
Market Cap:227.85M
PE:-15.67
High:8.49
Open:8.41
Low:8.10
Close:8.43
Loading ...
Apr 17, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 26, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 25, 2024

Major Issues Report

Form 8-K - Current report
Mar 21, 2024

Major Issues Report

Form 8-K - Current report
Mar 06, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Mar 01, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2024

Major Issues Report

Form 8-K - Current report
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 05, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 29, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 14, 2023

Correspondence

Form CORRESP - Correspondence
Dec 06, 2023

Major Issues Report

Form 8-K - Current report
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]